Brief: Lantheus Says On Aug 15 A Unit Decided To Discontinue Production & Promotion Of Azedra
18/08/2023 13:04
Aug 18 (Reuters) - Lantheus Holdings Inc LNTH.O :
* LANTHEUS HOLDINGS-ON AUG 15 PROGENICS PHARMACEUTICALS ,
UNIT OF
CO, SAID HAS MADE DECISION TO DISCONTINUE PRODUCTION & PROMOTION
OF AZEDRA
* LANTHEUS HOLDINGS-ON AUG 15 PROGENICS PHARMACEUTICALS ,
UNIT OF
CO, SAID WILL BE WINDING DOWN ITS SOMERSET, NJ MANUFACTURING
SITE
* LANTHEUS HOLDINGS INC - PROGENICS PHARMACEUTICALS'S
CURRENT
INTENT IS TO CONTINUE MANUFACTURING AZEDRA INTO Q1 OF 2024
Further company coverage: LNTH.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Lantheus Holdings
See all newsStreet View: Lantheus' tumor kit setback seen as temporary, with growth catalysts still ahead
Brief: Lantheus Receives Complete Response Letter From FDA For Lnth-2501 (Ga 68 Edotreotide)
US FDA declines Lantheus’ tumor imaging kit over third-party manufacturing issues (updated)
US FDA declines to approve Lantheus’ tumor imaging kit
$7 billion could be a 'light' price tag for Lantheus, Truist analysts say